Company / Operating Margin
Neurogene Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-8930.3%
FY2025
5-year range
-8930.3% / -150.6%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -4267% YoY in FY2025, a notable deviation from the 2-year average annual change of -2152%.
Based on SEC 10-K filings.
-8930.3% in FY2025.
Declined from -150.6% to -8930.3% over the past 7 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8930.3% | - |
| FY2024 | - | - |
| FY2019 | -204.5% | -35.8% |
| FY2018 | -150.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026